- Published on
Emergency and Acute Medicine – Barbiturates Poisoning
Overview and Definitions
Barbiturates are sedative–hypnotic agents derived from barbituric acid that exert their effects by enhancing γ-aminobutyric acid (GABA) activity at the GABA-A receptor. At toxic concentrations, they directly open chloride channels, leading to profound CNS depression. Additional effects include inhibition of vascular smooth muscle tone and direct myocardial depression, which contribute to hypotension and shock. Poisoning may be intentional or accidental.
Etiology
Toxicity results from overdose of barbiturates, either intentional (suicide attempt) or unintentional due to medication error, drug interactions, or dose escalation.
Clinical Features
Central nervous system findings range from lethargy, slurred speech, incoordination, ataxia, and loss of reflexes to deep coma that can closely resemble brain death. Cardiovascular manifestations include hypotension and bradycardia. Respiratory depression and hypothermia are common. Ophthalmologic findings may include miosis, nystagmus, and dysconjugate gaze. Characteristic bullae, known as “barb blisters,” may develop, particularly after prolonged immobilization.
History and Examination
Assessment should focus on determining intent, including evidence of pill bottles, history of depression or suicidal ideation, and recent medication changes. Estimating the duration of unresponsiveness is important. Examination typically reveals CNS depression ranging from ataxia to coma, respiratory compromise, hypotension, bradycardia, hypothermia, abnormal eye movements, and skin bullae.
Essential Evaluation
Immediate assessment includes fingerstick glucose, continuous oxygen saturation monitoring, and blood pressure measurement. A critical caution is that barbiturate poisoning can mimic brain death; this diagnosis must not be made until drug effects are excluded.
Diagnostic Testing
Laboratory studies include electrolytes, BUN, creatinine, glucose, and anion gap assessment, along with urinalysis for myoglobin and crystalluria, creatine phosphokinase for rhabdomyolysis, and urine toxicology screening. Serum phenobarbital levels should be obtained when suspected, with acetaminophen and salicylate levels assessed in possible suicide attempts. Imaging may include noncontrast head CT for altered mental status and chest radiography if aspiration is suspected. Lumbar puncture is reserved for selected cases where CNS infection is a concern.
Differential Diagnosis
Consider other sedative–hypnotic intoxications including GHB, carbon monoxide poisoning, CNS infections, intracranial mass lesions, hypoglycemia, uremia, electrolyte disturbances such as hypermagnesemia, postictal states, hypothyroidism, hepatic failure, and primary psychiatric conditions.
Prehospital Care
Moderate to severe poisonings require paramedic transport. Airway protection with intubation is often necessary due to respiratory depression or loss of protective reflexes. Supplemental oxygen, IV access, and fluid boluses for hypotension should be initiated promptly.
Initial Stabilization and Emergency Management
Management priorities follow ABC principles. Severe toxicity frequently necessitates endotracheal intubation and mechanical ventilation. Hypotension should be treated with aggressive isotonic fluid resuscitation, typically 1–2 liters of normal saline, with vasopressors added if shock persists. Activated charcoal effectively binds barbiturates and reduces absorption.
Therapeutic Interventions
A single dose of activated charcoal is most effective if administered within one hour of ingestion, provided the airway is protected. Repeated-dose activated charcoal may be used as “gut dialysis” every 2–4 hours if bowel sounds are present. Hypothermia should be corrected with active rewarming. Refractory hypotension requires vasopressor support. Hyperkalemia from rhabdomyolysis should be treated with standard therapies. Phenobarbital levels should be rechecked within 2–4 hours to assess trends. Hemodialysis is indicated in cases of renal failure, prolonged coma, phenobarbital levels above 100 mg/dL, or refractory hypotension. Urinary alkalinization has no role.
Medications
Activated charcoal is given at 1 g/kg orally. Dopamine may be initiated at 5–10 μg/kg/min and titrated as needed, with norepinephrine as an alternative at 2–4 μg/min. Epinephrine may be used as second-line vasopressor therapy.
Disposition and Follow-Up
ICU admission is required for patients with coma, respiratory depression, hypotension, hypothermia, or rhabdomyolysis. Discharge may be considered after at least six hours of observation in asymptomatic patients with two consecutive subtoxic phenobarbital levels. Intentional overdoses mandate psychiatric evaluation, while unintentional cases require medication review and adjustment.
Key Clinical Insights and Common Errors
Profound hypothermia is common and requires accurate core temperature measurement. Rhabdomyolysis should be actively sought, especially in patients with prolonged immobilization. Barbiturate toxicity can cause extended coma, and clinicians must ensure complete drug clearance before considering a diagnosis of brain death.
Overview and Definitions
Barbiturates are sedative–hypnotic agents derived from barbituric acid that exert their effects by enhancing γ-aminobutyric acid (GABA) activity at the GABA-A receptor. At toxic concentrations, they directly open chloride channels, leading to profound CNS depression. Additional effects include inhibition of vascular smooth muscle tone and direct myocardial depression, which contribute to hypotension and shock. Poisoning may be intentional or accidental.
Etiology
Toxicity results from overdose of barbiturates, either intentional (suicide attempt) or unintentional due to medication error, drug interactions, or dose escalation.
Clinical Features
Central nervous system findings range from lethargy, slurred speech, incoordination, ataxia, and loss of reflexes to deep coma that can closely resemble brain death. Cardiovascular manifestations include hypotension and bradycardia. Respiratory depression and hypothermia are common. Ophthalmologic findings may include miosis, nystagmus, and dysconjugate gaze. Characteristic bullae, known as “barb blisters,” may develop, particularly after prolonged immobilization.
History and Examination
Assessment should focus on determining intent, including evidence of pill bottles, history of depression or suicidal ideation, and recent medication changes. Estimating the duration of unresponsiveness is important. Examination typically reveals CNS depression ranging from ataxia to coma, respiratory compromise, hypotension, bradycardia, hypothermia, abnormal eye movements, and skin bullae.
Essential Evaluation
Immediate assessment includes fingerstick glucose, continuous oxygen saturation monitoring, and blood pressure measurement. A critical caution is that barbiturate poisoning can mimic brain death; this diagnosis must not be made until drug effects are excluded.
Diagnostic Testing
Laboratory studies include electrolytes, BUN, creatinine, glucose, and anion gap assessment, along with urinalysis for myoglobin and crystalluria, creatine phosphokinase for rhabdomyolysis, and urine toxicology screening. Serum phenobarbital levels should be obtained when suspected, with acetaminophen and salicylate levels assessed in possible suicide attempts. Imaging may include noncontrast head CT for altered mental status and chest radiography if aspiration is suspected. Lumbar puncture is reserved for selected cases where CNS infection is a concern.
Differential Diagnosis
Consider other sedative–hypnotic intoxications including GHB, carbon monoxide poisoning, CNS infections, intracranial mass lesions, hypoglycemia, uremia, electrolyte disturbances such as hypermagnesemia, postictal states, hypothyroidism, hepatic failure, and primary psychiatric conditions.
Prehospital Care
Moderate to severe poisonings require paramedic transport. Airway protection with intubation is often necessary due to respiratory depression or loss of protective reflexes. Supplemental oxygen, IV access, and fluid boluses for hypotension should be initiated promptly.
Initial Stabilization and Emergency Management
Management priorities follow ABC principles. Severe toxicity frequently necessitates endotracheal intubation and mechanical ventilation. Hypotension should be treated with aggressive isotonic fluid resuscitation, typically 1–2 liters of normal saline, with vasopressors added if shock persists. Activated charcoal effectively binds barbiturates and reduces absorption.
Therapeutic Interventions
A single dose of activated charcoal is most effective if administered within one hour of ingestion, provided the airway is protected. Repeated-dose activated charcoal may be used as “gut dialysis” every 2–4 hours if bowel sounds are present. Hypothermia should be corrected with active rewarming. Refractory hypotension requires vasopressor support. Hyperkalemia from rhabdomyolysis should be treated with standard therapies. Phenobarbital levels should be rechecked within 2–4 hours to assess trends. Hemodialysis is indicated in cases of renal failure, prolonged coma, phenobarbital levels above 100 mg/dL, or refractory hypotension. Urinary alkalinization has no role.
Medications
Activated charcoal is given at 1 g/kg orally. Dopamine may be initiated at 5–10 μg/kg/min and titrated as needed, with norepinephrine as an alternative at 2–4 μg/min. Epinephrine may be used as second-line vasopressor therapy.
Disposition and Follow-Up
ICU admission is required for patients with coma, respiratory depression, hypotension, hypothermia, or rhabdomyolysis. Discharge may be considered after at least six hours of observation in asymptomatic patients with two consecutive subtoxic phenobarbital levels. Intentional overdoses mandate psychiatric evaluation, while unintentional cases require medication review and adjustment.
Key Clinical Insights and Common Errors
Profound hypothermia is common and requires accurate core temperature measurement. Rhabdomyolysis should be actively sought, especially in patients with prolonged immobilization. Barbiturate toxicity can cause extended coma, and clinicians must ensure complete drug clearance before considering a diagnosis of brain death.
0 Comments
